Science News
from research organizations

Breast cancer: Disease management program is largely consistent with guidelines

Date:
July 16, 2014
Source:
Institute for Quality and Efficiency in Health Care
Summary:
There are only few discrepancies between the disease management program for breast cancer and current guidelines. However, some of the guidelines are more detailed. A need for revision may arise if new studies provide new evidence on a disease and its treatment.
Share:
         
Total shares:  
FULL STORY

On 16 July 2014 the German Institute for Quality and Efficiency in Health Care (IQWiG) published the results of a literature search for evidence-based clinical practice guidelines on the treatment of people with breast cancer. The aim of the report is to identify those recommendations from current guidelines of high methodological quality that may be relevant for the planned revision of the disease management programme (DMP). According to the results of the report, there is no compelling need for revision of any part of the DMP. However, IQWiG identified some aspects that could be supplemented and specified.

DMPs are revised regularly

After being commissioned by the Federal Joint Committee (G-BA), IQWiG systematically searched for new guidelines, assessed their methodological quality, and extracted relevant recommendations from these guidelines. In a next step these recommendations were compared with the specifications for the German DMP.

A need for revision may arise if new studies provide new evidence on a disease and its treatment. It is therefore legally specified that a DMP must be revised at regular intervals. It is the Institute's responsibility to firstly identify differences between the guideline recommendations and the DMP. It is then the G-BA'sresponsibility to examine whether these differences should actually lead to a revision of the DMP.

26 relevant guidelines identified

IQWiG was able to include a total of 26 guidelines in its investigation. Six of these guidelines comprehensively address the care of patients with breast cancer. Seven guidelines exclusively deal with early breast cancer, four further guidelines with advanced breast cancer (stage IV). The remaining nine guidelines address specific aspects such as radiotherapy, breast reconstruction or adjuvant systematic treatment.

Supplementations desirable

As IQWiG determined, there are several health-care aspects for which the recommendations of the DMP should be revised. Among other aspects, this applies to diagnostics and measures in primary therapy: The guidelines address the performance of a magnetic resonance imaging (MRI) scan in specific therapeutic indications, explicitly advising against routine MRI scans. With regard to radiotherapy for breast cancer, the guidelines provide recommendations on hypofractionated radiotherapy -- an aspect currently not considered by the DMP.


Story Source:

The above story is based on materials provided by Institute for Quality and Efficiency in Health Care. Note: Materials may be edited for content and length.


Cite This Page:

Institute for Quality and Efficiency in Health Care. "Breast cancer: Disease management program is largely consistent with guidelines." ScienceDaily. ScienceDaily, 16 July 2014. <www.sciencedaily.com/releases/2014/07/140716095829.htm>.
Institute for Quality and Efficiency in Health Care. (2014, July 16). Breast cancer: Disease management program is largely consistent with guidelines. ScienceDaily. Retrieved April 28, 2015 from www.sciencedaily.com/releases/2014/07/140716095829.htm
Institute for Quality and Efficiency in Health Care. "Breast cancer: Disease management program is largely consistent with guidelines." ScienceDaily. www.sciencedaily.com/releases/2014/07/140716095829.htm (accessed April 28, 2015).

Share This Page:


Recommended Content
 


Health & Medicine News
April 28, 2015

Latest Headlines
updated 12:56 pm ET